Shares of Puration Inc (OTCMKTS:PURA) continued to trend in the previous trading session after the recent fall.
Trading Data
On Wednesday, PURA stock fell 4.80% to $0.0139 with more than 1.51 million, compared to its average volume of 4.60 million shares. The stock has moved within a range of $0.0135 – 0.0151 after opening the trade at $0.0140.
Latest News
PAO Group and Puration Inc (OTCMKTS:PURA) are all set to form a partnership that is dedicated towards developing a batch of CBD products, targeted towards Women’s Health. PAO Group has said that the product line will be developed under the supervision of Dr. Harriet Kamendi, a graduate of Howard University’s Department of Pharmacology with post-doctoral studies at George Washington University.
Dr. Kamendi has garnered various accolades throughout his long and distinguished career. He is an extensively published and recognized healthcare research scientist, and has a prominent research background with CBD. PAO Group is also teaming up with Alkame Holdings for special packaging requirements.
The new CBD product line aimed at Women’s Health is the very first product partnership between PAO Group and Puration Inc. under the latter’s Farmersville Hemp Brand initiative. In 2020, PAO Group acquired intellectual derived through research into CBD extracted in association with a patented extraction method. Based on this intellectual property, the company is developing nutraceutical and pharmaceutical treatments for humans. Quite recently two CBD nutraceutical products have been launched as well – RelaxRX CBD (sleep aid) and RehabRX CBD (salve).
Things are looking up for the PAO Group, as they are about to realize their first revenue in 2021, starting from Q4, ever since acquiring the extraction technology.
Technical Data
PURA stock is trading below the 20-Day and 50-Day Moving averages of $0.0155 and $0.0160 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0183. The stock is down 29% in the past month.
